• Ophthalmic Business Council

    For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.

    OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.

    To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.

    Download brochures: AAO 2022-23 exhibitors and non-exhibitors

    Save the Date


    Fall 2022 Symposium
    Sept. 8-9, 2022
    San Francisco, Calif.

    Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.


    Spring 2023 Symposium
    Apr. 20, 2023
    Washington, DC

    The Spring Symposium is held every other year in Washington, D.C. It features experts from government agencies presenting updates on FDA, Medicare and reimbursement issues. As the speed of innovation and new knowledge in ophthalmology grows, this event has become increasingly valuable in providing helpful insights for bringing new technologies and procedures to patients. 

    Member Benefits

    2022 - 2023 Ophthalmic Business Council 

    Crown Benefactors ($35,000)

    Alcon, Inc.
    Allergan, an AbbVie Company
    Biogen
    Genentech, Inc.
    Horizon Therapeutics
    Novartis Pharmaceuticals
    Regeneron Pharmaceuticals, Inc.

     
    Benefactors ($25,000)

    The Janssen Pharmaceutical Companies of Johnson & Johnson
    Santen, Inc.
    Sight Sciences, Inc.


    Patrons ($15,000)

    Amgen, Inc.
    Bausch + Lomb
    Carl Zeiss Meditec, Inc.
    Dompé
    EyePoint Pharmaceuticals
    Johnson & Johnson Vision
    Mallinckrodt Pharmaceuticals
    Ocular Therapeutix
    Optos, Inc.

     
    Subscribers ($7,500)

    Aerie Pharmaceuticals, Inc.
    Bio-Tissue, Inc.
    Glaukos Corporation
    Leadiant Biosciences, Inc.
    Notal Vision
    Outlook Therapeutics
    REGENXBIO, Inc.
    Sun Ophthalmics
    Tarsus Pharmaceuticals, Inc.
    Verana Health
    Vyluma



    Members ($5,000)

    Apellis Pharmaceuticals


    Associate Members ($2,500)

    Aura Biosciences, Inc.
    Centricity Vision, Inc.
    Immunovant, Inc.
    W. L. Gore & Associates